永续医药包装市场－全球产业规模、份额、趋势、机会及预测（依材料、製程、产品类型、最终用户、地区及竞争格局划分，2021-2031年）

全球永续药品包装市场预计将从 2025 年的 855 亿美元成长到 2031 年的 1,392.6 亿美元，复合年增长率为 8.47%。

该市场涵盖以可再生、可回收和可生物降解材料製成的药品包装解决方案的贸易，旨在最大限度地减少对环境的影响，同时保持产品完整性。主要驱动因素包括政府对减少废弃物的严格监管，以及大型製药公司所製定的雄心勃勃的环境、社会和管治 ( ESG) 目标。此外，消费者对塑胶污染日益增强的意识也促使企业转向循环经济模式。根据医疗塑胶回收委员会 (Medical 塑胶回收再利用 Council) 2024 年的报告显示，医疗保健产业将占全球温室气体排放的 4.4%，这凸显了对这些环保创新技术的迫切需求。

儘管存在这些驱动因素，但由于严格的监管合规标准，该行业仍面临着许多障碍，这些障碍可能会阻碍市场的快速成长。为确保新型永续材料不会影响药物稳定性或病人安全，需要进行复杂的检验流程，这通常会导致更长的研发週期和更高的营运成本。这些要求最终将减缓绿色替代品的普及，因为製造商必须应对复杂的测试，以确保环保材料的性能与传统材料相当。

市场驱动因素

政府严格的环境法规的实施是全球永续药品包装市场的主要驱动力。立法者已强制要求打破传统的「取得、製造、丢弃」的线性模式，迫使製造商采用既能确保可回收性又不影响药品安全性的包装解决方案。这种监管压力促使人们即时思考包装设计，从而淘汰原生塑料，并将消费后回收材料整合到无菌屏障系统中。例如，欧洲理事会于2024年12月最终确定的《关于永续包装的新法规》规定，到2030年，市场上100%的包装必须可回收，引导产业走向单一材料结构和可生物降解的替代方案。

同时，企业对环境、社会及治理（ESG）和永续性发展的日益重视正在推动变革，主要产业参与者正调整其营运以符合脱碳目标，从而降低声誉风险并吸引具有环保意识的相关人员。製药公司越来越重视生态设计原则和营运效率，不断扩大生物基和循环材料的市场占有率。创新是这项转变的核心。安姆科（Amcor）于2025年10月发布的《2025年永续发展报告》重点介绍了其突破性成就：使其96%的软包装产品系列可回收。此外，阿普塔尔（Aptar）于2025年5月发布的《2024年企业永续发展报告》也重点介绍了该公司如何透过再利用和回收倡议，将86%的营运废弃物从掩埋转移出去，这体现了整个行业对资源效率的承诺。

市场挑战

医药产业严格的合规标准对永续包装解决方案的快速普及构成了重大障碍。与其他行业包装变革可以相对迅速地实施不同，医药包装必须将病人安全和药物稳定性放在首位。因此，向新型可再生或可生物降解材料的过渡需要大量的验证流程，以检验其与传统材料一样具有防潮、防光和防污染性能。这些强制性且复杂的测试程序显着延长了研发週期，增加了营运成本，从而减缓了环保替代产品的上市速度。

这种监管瓶颈直接阻碍了市场成长，因为它为材料创新设置了很高的进入门槛。由于检验现有产品不确定性且耗费大量资源，製造商不愿投资更环保的替代方案。产业数据也印证了永续性目标与合规义务之间的这种摩擦。根据欧洲製药工业协会联合会 (EFPIA) 发布的《2024 年循环经济白皮书》，70% 的受访产业人士认为监管要求是实施循环经济倡议的最大挑战之一。这项数据凸显了新材料监管柔软性的不足如何阻碍了产业有效扩大其永续足迹的能力。

市场趋势

采用具备NFC和RFID追踪功能的智慧包装正在从根本上改变整个产业，提升价值链的透明度，并增强病患安全。这些技术不再局限于简单的序列化以满足监管要求，而是用于即时库存管理和数位化首开检验，这对于高价值注射剂至关重要。这种整合使医院能够自动进行完整性检查和有效期限监控，从而显着减少药物滥用和营运浪费。根据《包装策略》杂誌2024年10月刊的报导“Schreiner MediPharm重点介绍RFID标籤解决方案”，该公司的RFID标籤技术已成功实现了北美医院超过3.25亿剂注射用急救和麻醉剂的数位化追踪，充分展现了智能连接在改善药品物流方面的巨大潜力。

同时，采用先进的化学回收技术正成为解决产业材料品质挑战的关键方案。机械回收通常无法满足无菌屏障系统所需的严格纯度标准，而分子级回收则能将废弃塑胶分解成单体成分，生产出适用于封装敏感药物的优质原生树脂。这种技术方法正在扩大符合严格监管检验要求的循环材料的供应。根据《包装世界》（Pack World）2024年3月刊题为「伊士曼公司获得高达3.75亿美元的资金筹措」的报导，该公司已获得资金用于建设一座分子回收设施，该设施每年可处理约11万吨难降解塑胶废弃物。这项进展将显着增加用于製药应用的高品质循环聚合物原料的供应。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球永续医药包装市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依材质（纸、玻璃、金属、塑胶）
  • 依生产过程（可重复使用包装、可生物降解包装、回收包装）
  • 依产品类型（瓶子、盖子与封口装置、包装袋/小袋、其他）
  • 依最终用户（药品生产、合约包装、零售药局、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美永续药品包装市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲永续药品包装市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区永续医药包装市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲永续药品包装市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲永续药品包装市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球永续医药包装市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Amcor plc
• WestRock Company
• Schott AG
• Sonoco Products Company
• Berry Global Group, Inc.
• Mondi plc
• Smurfit Kappa Group plc
• Sealed Air Corporation
• DS Smith Plc
• KOrber AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Sustainable Pharmaceutical Packaging Market is projected to expand from USD 85.50 Billion in 2025 to USD 139.26 Billion by 2031, registering a CAGR of 8.47%. This market encompasses the trade of drug containment solutions manufactured from renewable, recyclable, or biodegradable materials, aiming to minimize environmental impact while preserving product integrity. Primary drivers include strict government regulations on waste reduction and ambitious environmental, social, and governance targets established by major pharmaceutical corporations. Furthermore, rising consumer awareness regarding plastic pollution is pushing companies toward circular economy models. As reported by the Healthcare Plastics Recycling Council in 2024, the healthcare industry accounted for 4.4% of global greenhouse gas emissions, underscoring the critical need for these eco-friendly advancements.

Despite these drivers, the sector encounters significant hurdles due to rigorous regulatory compliance standards that can hinder rapid market growth. The intricate validation processes necessary to ensure that new sustainable materials do not jeopardize drug stability or patient safety often lead to prolonged development schedules and higher operational expenses. These requirements ultimately delay the adoption of greener alternatives, as manufacturers must navigate complex testing to verify that eco-friendly options perform on par with traditional materials.

Market Driver

The enforcement of strict government environmental regulations serves as a primary catalyst for the Global Sustainable Pharmaceutical Packaging Market. Legislative bodies are implementing rigorous mandates to dismantle the linear "take-make-dispose" model, requiring manufacturers to adopt containment solutions that ensure recoverability without sacrificing drug safety. This regulatory pressure is forcing an immediate overhaul of packaging designs, leading to the elimination of non-recyclable plastics and the integration of post-consumer recycled content into sterile barrier systems. For instance, the European Council's finalized regulation in December 2024, titled 'Adoption of new rules for sustainable packaging', mandates that 100% of all packaging placed on the market must be recyclable by 2030, a directive driving the industry toward mono-material structures and biodegradable alternatives.

Simultaneously, the rising corporate emphasis on ESG and sustainability mandates is transformative, as major industry players align operations with decarbonization goals to mitigate reputational risks and appeal to environmentally conscious stakeholders. Pharmaceutical entities are increasingly prioritizing eco-design principles and operational efficiency, boosting the market share of bio-based and circular materials. Technological innovation is central to this shift; Amcor's 'Fiscal 2025 Sustainability Report' from October 2025 notes that the company achieved a milestone where 96% of its flexible packaging portfolio is now recycle-ready. Furthermore, Aptar's '2024 Corporate Sustainability Report' from May 2025 highlights that the firm avoided landfill disposal for 86% of its operational waste through reuse and recovery initiatives, reflecting a sector-wide commitment to resource efficiency.

Market Challenge

The rigorous regulatory compliance standards governing the pharmaceutical industry present a formidable barrier to the rapid adoption of sustainable packaging solutions. Unlike other sectors where packaging changes can be implemented relatively quickly, pharmaceutical packaging must primarily ensure patient safety and drug stability. Consequently, any transition to novel renewable or biodegradable materials requires extensive validation processes to verify that they offer the same level of protection against moisture, light, and contamination as traditional materials. These mandatory and complex testing procedures significantly extend development timelines and inflate operational costs, thereby reducing the speed at which eco-friendly alternatives can be brought to market.

This regulatory bottleneck directly hampers market growth by creating a high threshold for material innovation. Manufacturers face hesitation in investing in greener alternatives due to the uncertainty and resource intensity associated with re-validating existing products. This friction between sustainability goals and compliance obligations is substantiated by industry data. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in its 2024 White Paper on the Circular Economy, 70% of industry respondents identified regulatory requirements as one of the greatest challenges when implementing circular economy initiatives. This statistic underscores how the lack of regulatory flexibility for new materials stifles the sector's ability to expand its sustainable footprint effectively.

Market Trends

The implementation of smart packaging with NFC and RFID tracking is fundamentally reshaping the sector by enhancing supply chain visibility and patient safety. Beyond simple serialization for regulatory compliance, these technologies are now being leveraged for real-time inventory management and digital first-opening verification, which are critical for high-value injectable drugs. This integration allows hospitals to automate integrity checks and expiration monitoring, significantly reducing medication errors and operational waste. According to Packaging Strategies, October 2024, in the article 'Schreiner MediPharm to Highlight RFID Label Solutions', the company's RFID labeling technology has successfully enabled the digital tracking of over 325 million units of injectable emergency and anesthetic drugs in North American hospitals, demonstrating the scale at which intelligent connectivity is improving pharmaceutical logistics.

Simultaneously, the incorporation of advanced chemical recycling technologies is emerging as a vital solution to the industry's material quality challenges. While mechanical recycling often fails to meet the stringent purity standards required for sterile barrier systems, molecular recycling depolymerizes waste plastics into their monomer building blocks, allowing for the creation of virgin-quality resins suitable for sensitive drug containment. This technological pathway is unlocking the availability of circular materials that satisfy rigorous regulatory validation requirements. According to Pack World, March 2024, in the article 'Eastman Awarded Up To $375 Million', the company secured funding to construct a molecular recycling facility with the capacity to process approximately 110,000 metric tons of hard-to-recycle plastic waste annually, a development that substantially increases the feedstock of high-grade circular polymers available for pharmaceutical applications.

Key Market Players

• Amcor plc
• WestRock Company
• Schott AG
• Sonoco Products Company
• Berry Global Group, Inc.
• Mondi plc
• Smurfit Kappa Group plc
• Sealed Air Corporation
• DS Smith Plc
• KOrber AG

Report Scope

In this report, the Global Sustainable Pharmaceutical Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sustainable Pharmaceutical Packaging Market, By Material

• Paper
• Glass
• Metal
• Plastic

Sustainable Pharmaceutical Packaging Market, By Process

• Reusable Packaging
• Biodegradable Packaging
• Recycled Packaging

Sustainable Pharmaceutical Packaging Market, By Product Type

• Bottles
• Caps & Closures
• Pouches & Sachets
• Others

Sustainable Pharmaceutical Packaging Market, By End User

• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Others

Sustainable Pharmaceutical Packaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sustainable Pharmaceutical Packaging Market.

Available Customizations:

Global Sustainable Pharmaceutical Packaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sustainable Pharmaceutical Packaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material (Paper, Glass, Metal, Plastic)
  • 5.2.2. By Process (Reusable Packaging, Biodegradable Packaging, Recycled Packaging)
  • 5.2.3. By Product Type (Bottles, Caps & Closures, Pouches & Sachets, Others)
  • 5.2.4. By End User (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Sustainable Pharmaceutical Packaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Process
  • 6.2.3. By Product Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Sustainable Pharmaceutical Packaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material
      • 6.3.1.2.2. By Process
      • 6.3.1.2.3. By Product Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Sustainable Pharmaceutical Packaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material
      • 6.3.2.2.2. By Process
      • 6.3.2.2.3. By Product Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Sustainable Pharmaceutical Packaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material
      • 6.3.3.2.2. By Process
      • 6.3.3.2.3. By Product Type
      • 6.3.3.2.4. By End User

7. Europe Sustainable Pharmaceutical Packaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Process
  • 7.2.3. By Product Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Sustainable Pharmaceutical Packaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material
      • 7.3.1.2.2. By Process
      • 7.3.1.2.3. By Product Type
      • 7.3.1.2.4. By End User
  • 7.3.2. France Sustainable Pharmaceutical Packaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material
      • 7.3.2.2.2. By Process
      • 7.3.2.2.3. By Product Type
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Sustainable Pharmaceutical Packaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material
      • 7.3.3.2.2. By Process
      • 7.3.3.2.3. By Product Type
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Sustainable Pharmaceutical Packaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material
      • 7.3.4.2.2. By Process
      • 7.3.4.2.3. By Product Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Sustainable Pharmaceutical Packaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material
      • 7.3.5.2.2. By Process
      • 7.3.5.2.3. By Product Type
      • 7.3.5.2.4. By End User

8. Asia Pacific Sustainable Pharmaceutical Packaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Process
  • 8.2.3. By Product Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Sustainable Pharmaceutical Packaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material
      • 8.3.1.2.2. By Process
      • 8.3.1.2.3. By Product Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Sustainable Pharmaceutical Packaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material
      • 8.3.2.2.2. By Process
      • 8.3.2.2.3. By Product Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Sustainable Pharmaceutical Packaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material
      • 8.3.3.2.2. By Process
      • 8.3.3.2.3. By Product Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Sustainable Pharmaceutical Packaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Material
      • 8.3.4.2.2. By Process
      • 8.3.4.2.3. By Product Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Sustainable Pharmaceutical Packaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Material
      • 8.3.5.2.2. By Process
      • 8.3.5.2.3. By Product Type
      • 8.3.5.2.4. By End User

9. Middle East & Africa Sustainable Pharmaceutical Packaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Process
  • 9.2.3. By Product Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Sustainable Pharmaceutical Packaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material
      • 9.3.1.2.2. By Process
      • 9.3.1.2.3. By Product Type
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Sustainable Pharmaceutical Packaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material
      • 9.3.2.2.2. By Process
      • 9.3.2.2.3. By Product Type
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Sustainable Pharmaceutical Packaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material
      • 9.3.3.2.2. By Process
      • 9.3.3.2.3. By Product Type
      • 9.3.3.2.4. By End User

10. South America Sustainable Pharmaceutical Packaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Process
  • 10.2.3. By Product Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Sustainable Pharmaceutical Packaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material
      • 10.3.1.2.2. By Process
      • 10.3.1.2.3. By Product Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Sustainable Pharmaceutical Packaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material
      • 10.3.2.2.2. By Process
      • 10.3.2.2.3. By Product Type
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Sustainable Pharmaceutical Packaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material
      • 10.3.3.2.2. By Process
      • 10.3.3.2.3. By Product Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Sustainable Pharmaceutical Packaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Amcor plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. WestRock Company
• 15.3. Schott AG
• 15.4. Sonoco Products Company
• 15.5. Berry Global Group, Inc.
• 15.6. Mondi plc
• 15.7. Smurfit Kappa Group plc
• 15.8. Sealed Air Corporation
• 15.9. DS Smith Plc
• 15.10. KOrber AG

16. Strategic Recommendations

17. About Us & Disclaimer